Matthew C Mishkind1, Aaron M Norr2, Andrea C Katz2, Greg M Reger2,3. 1. Helen and Arthur E. Johnson Depression Center, University of Colorado School of Medicine, Aurora, CO, USA. matthew.mishkind@ucdenver.edu. 2. VA Puget Sound Health Care System, Seattle, WA, USA. 3. University of Washington School of Medicine, Seattle, USA.
Abstract
PURPOSE OF REVIEW: This review provides an overview of the current evidence base for and clinical applications of the use of virtual reality (VR) in psychiatric practice, in context of recent technological developments. RECENT FINDINGS: The use of VR in psychiatric practice shows promise with much of the research demonstrating clinical effectiveness for conditions including post-traumatic stress disorder, anxiety and phobias, chronic pain, rehabilitation, and addictions. However, more research is needed before the use of VR is considered a clinical standard of practice in some areas. The recent release of first generation consumer VR products signals a change in the viability of further developing VR systems and applications. As applications increase so will the need for good quality research to best understand what makes VR effective, and when VR is not appropriate for clinical services. As the field progresses, it is hopeful that the flexibility afforded by this technology will yield superior outcomes and a better understanding of the underlying mechanisms impacting those outcomes.
PURPOSE OF REVIEW: This review provides an overview of the current evidence base for and clinical applications of the use of virtual reality (VR) in psychiatric practice, in context of recent technological developments. RECENT FINDINGS: The use of VR in psychiatric practice shows promise with much of the research demonstrating clinical effectiveness for conditions including post-traumatic stress disorder, anxiety and phobias, chronic pain, rehabilitation, and addictions. However, more research is needed before the use of VR is considered a clinical standard of practice in some areas. The recent release of first generation consumer VR products signals a change in the viability of further developing VR systems and applications. As applications increase so will the need for good quality research to best understand what makes VR effective, and when VR is not appropriate for clinical services. As the field progresses, it is hopeful that the flexibility afforded by this technology will yield superior outcomes and a better understanding of the underlying mechanisms impacting those outcomes.
Authors: Francis J Keefe; Dane A Huling; Michael J Coggins; Daniel F Keefe; Zachary M Rosenthal; Nathaniel R Herr; Hunter G Hoffman Journal: Pain Date: 2012-07-04 Impact factor: 6.961
Authors: Russell A McCann; Christina M Armstrong; Nancy A Skopp; Amanda Edwards-Stewart; Derek J Smolenski; Jennifer D June; Melinda Metzger-Abamukong; Greg M Reger Journal: J Anxiety Disord Date: 2014-06-07
Authors: Hunter G Hoffman; Gloria T Chambers; Walter J Meyer; Lisa L Arceneaux; William J Russell; Eric J Seibel; Todd L Richards; Sam R Sharar; David R Patterson Journal: Ann Behav Med Date: 2011-04
Authors: Matthew J Smith; Emily J Ginger; Michael Wright; Katherine Wright; Laura Boteler Humm; Dale Olsen; Morris D Bell; Michael F Fleming Journal: J Nerv Ment Dis Date: 2014-09 Impact factor: 2.254
Authors: Gian Luca Cesa; Gian Mauro Manzoni; Monica Bacchetta; Gianluca Castelnuovo; Sara Conti; Andrea Gaggioli; Fabrizia Mantovani; Enrico Molinari; Georgina Cárdenas-López; Giuseppe Riva Journal: J Med Internet Res Date: 2013-06-12 Impact factor: 5.428
Authors: Rosalba Hernandez; Brett Burrows; Matthew H E M Browning; Killivalavan Solai; Drew Fast; Natalia O Litbarg; Kenneth R Wilund; Judith T Moskowitz Journal: Kidney360 Date: 2021-01-08
Authors: Dan J Stein; Steven J Shoptaw; Daniel V Vigo; Crick Lund; Pim Cuijpers; Jason Bantjes; Norman Sartorius; Mario Maj Journal: World Psychiatry Date: 2022-10 Impact factor: 79.683
Authors: Santiago Papini; Cara C Young; Catherine S Gebhardt; Alex Perrone; Hitoshi Morikawa; Michael W Otto; John D Roache; Jasper A J Smits Journal: Contemp Clin Trials Date: 2020-04-24 Impact factor: 2.226
Authors: Matthew P White; Nicola L Yeo; Peeter Vassiljev; Rikard Lundstedt; Mattias Wallergård; Maria Albin; Mare Lõhmus Journal: Neuropsychiatr Dis Treat Date: 2018-11-08 Impact factor: 2.570